Milestones
2019 - Today
As a result of its agreement with PharmaVision San.ve Tic. A.S., INC Pharma implemented the Co-Marketing business model for the first time in its history and added 12 new SKUs to its portfolio
2019
2018
With the number of its generics reaching 14, INC Pharma widened its portfolio to 564 SKUs through new agreements with domestic manufacturers.
2017
Through its agreement with Mustafa Nevzat Ilac San. ve Tic. A.S. ,an AMGEN subsidiary, INC Pharma created a new international business model with a third party for the first time and started its operations.
2016
INC Pharma obtained its first manufacturing license and launched its first licensed product into the Turkish market.
2014
INC Pharma took the first step into pharmaceutical manufacturing.
2013
INC Pharma took the first step into pharmaceutical manufacturing.
2012
INC Pharma was founded as a pharmaceutical company with 100% Turkish capital.
